Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 688.00 | |
50 mg | 6-8 weeks | $ 913.00 | |
100 mg | 6-8 weeks | $ 1,390.00 |
Description | LTV-1 has the potential for autoimmunity treatment. LTV-1 is a potent lymphoid tyrosine phosphatase (LYP) inhibitor in T cells with an IC50 of 508 nM. |
Targets&IC50 | LYP (T cells):508 nM |
In vitro | LTV-1 is not cytotoxic in HeLa cells, Jurkat TAg T cells and peripheral blood mononuclear cells (PBMC)[1].even at the highest concentration tested (40 μM). |
Molecular Weight | 472.51 |
Formula | C26H20N2O5S |
CAS No. | 347379-29-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (105.82 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LTV-1 347379-29-7 Others LTV1 LTV 1 inhibitor inhibit